Mustang Bio, Inc.

DB:2W60 Stock Report

Market Cap: €46.2m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Mustang Bio Management

Management criteria checks 2/4

Mustang Bio's CEO is Manny Litchman, appointed in Apr 2017, has a tenure of 6.25 years. total yearly compensation is $656.67K, comprised of 71.3% salary and 28.7% bonuses, including company stock and options. directly owns 1.31% of the company’s shares, worth €603.68K. The average tenure of the management team and the board of directors is 2 years and 7.1 years respectively.

Key information

Manny Litchman

Chief executive officer

US$656.7k

Total compensation

CEO salary percentage71.3%
CEO tenure6.3yrs
CEO ownership1.3%
Management average tenure2yrs
Board average tenure7.1yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Manny Litchman's remuneration changed compared to Mustang Bio's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2023n/an/a

-US$74m

Dec 31 2022US$657kUS$468k

-US$78m

Sep 30 2022n/an/a

-US$78m

Jun 30 2022n/an/a

-US$76m

Mar 31 2022n/an/a

-US$71m

Dec 31 2021US$885kUS$450k

-US$66m

Sep 30 2021n/an/a

-US$67m

Jun 30 2021n/an/a

-US$63m

Mar 31 2021n/an/a

-US$63m

Dec 31 2020US$1mUS$430k

-US$60m

Sep 30 2020n/an/a

-US$56m

Jun 30 2020n/an/a

-US$53m

Mar 31 2020n/an/a

-US$49m

Dec 31 2019US$517kUS$415k

-US$46m

Sep 30 2019n/an/a

-US$42m

Jun 30 2019n/an/a

-US$39m

Mar 31 2019n/an/a

-US$34m

Dec 31 2018US$606kUS$403k

-US$31m

Sep 30 2018n/an/a

-US$34m

Jun 30 2018n/an/a

-US$34m

Mar 31 2018n/an/a

-US$34m

Dec 31 2017US$6mUS$267k

-US$31m

Compensation vs Market: Manny's total compensation ($USD656.67K) is above average for companies of similar size in the German market ($USD418.12K).

Compensation vs Earnings: Manny's compensation has been consistent with company performance over the past year.

CEO

Manny Litchman (69 yo)

6.3yrs

Tenure

US$656,672

Compensation

Dr. Manuel Litchman, also known as Manny, M.D. has been the President, Chief Executive Officer and Director at Mustang Bio Inc. since April 24, 2017. Dr. Litchman served as the Chief Executive Officer and...

Leadership Team

NamePositionTenureCompensationOwnership
Michael Weiss
Executive Chairman8.2yrsUS$110.00k0.11%
€ 51.5k
Manuel Litchman
President6.3yrsUS$656.67k1.31%
€ 603.7k
Eliot Lurier
Interim Chief Financial Officer1.3yrsUS$282.83kno data
Greg Furrow
Interim CTOless than a yearno datano data
Matthew Wein
VP & General Counsel1.8yrsno datano data
Debra Manning
Senior Vice President of Human Resources4.5yrsno datano data
Bruce Dezube
Senior VP & Head of Clinical Development2.1yrsno datano data
Rick Bodmer
VP & Head of CMC Developmentless than a yearno datano data
Robyn Hunter
Corporate Secretaryno datano datano data

2.0yrs

Average Tenure

63yo

Average Age

Experienced Management: 2W60's management team is not considered experienced ( 2 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Michael Weiss
Executive Chairman8.2yrsUS$110.00k0.11%
€ 51.5k
Manuel Litchman
President6.3yrsUS$656.67k1.31%
€ 603.7k
Lindsay Rosenwald
Non-Executive Director8.3yrsUS$100.00k0.25%
€ 113.5k
Michael Zelefsky
Independent Director6.1yrsUS$100.00k0.14%
€ 66.7k
Neil Herskowitz
Independent & Non-Executive Director7.9yrsUS$100.00k0.15%
€ 70.9k
Adam Chill
Independent Director6.1yrsUS$110.00k0.15%
€ 67.9k

7.1yrs

Average Tenure

64.5yo

Average Age

Experienced Board: 2W60's board of directors are considered experienced (7.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/07/01 12:44
End of Day Share Price 2023/04/03 00:00
Earnings2023/03/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Mustang Bio, Inc. is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mayank MamtaniB. Riley Securities, Inc.
Justin ZelinB. Riley Securities, Inc.
Jonathan AschoffB. Riley Wealth